Next Article in Journal
Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
Next Article in Special Issue
BET Proteins Regulate Expression of Osr1 in Early Kidney Development
Previous Article in Journal
Novel Coagulation Factor VIII Gene Therapy in a Mouse Model of Hemophilia A by Lipid-Coated Fe3O4 Nanoparticles
Previous Article in Special Issue
Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 9
Issue 9
10.3390/biomedicines9091117
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Glomerular Mesangial Cell pH Homeostasis Mediates Mineralocorticoid Receptor-Induced Cell Proliferation

by
Michael Gekle
* and
Sigrid Mildenberger
Julius-Bernstein-Institut für Physiologie, Martin-Luther-Universität Halle-Wittenberg, 06112 Halle (Saale), Germany
*
Author to whom correspondence should be addressed.
Biomedicines 2021, 9(9), 1117; https://doi.org/10.3390/biomedicines9091117
Submission received: 14 July 2021 / Revised: 24 August 2021 / Accepted: 27 August 2021 / Published: 30 August 2021
(This article belongs to the Special Issue Glomerular Microenvironment: Cellular Stress in Chronic Kidney Disease)
Browse Figures
Review Reports Versions Notes

Abstract

:
Mineralocorticoids (e.g., aldosterone) support chronic inflammatory tissue damage, including glomerular mesangial injury leading to glomerulosclerosis. Furthermore, aldosterone leads to activation of the extracellular signal-regulated kinases (ERK1/2) in rat glomerular mesangial cells (GMC). Because ERK1/2 can affect cellular pH homeostasis via activation of Na+/H+-exchange (NHE) and the resulting cellular alkalinization may support proliferation, we tested the hypothesis that aldosterone affects pH homeostasis and thereby cell proliferation as well as collagen secretion also in primary rat GMC. Cytoplasmic pH and calcium were assessed by single-cell fluorescence ratio imaging, using the dyes BCECF or FURA2, respectively. Proliferation was determined by cell counting, thymidine incorporation and collagen secretion by collagenase-sensitive proline incorporation and ERK1/2-phosphorylation by Western blot. Nanomolar aldosterone induces a rapid cytosolic alkalinization which is prevented by NHE inhibition (10 µmol/L EIPA) and by blockade of the mineralocorticoid receptor (100 nmol/L spironolactone). pH changes were not affected by inhibition of HCO3− transporters and were not dependent on HCO3−. Aldosterone enhanced ERK1/2 phosphorylation and inhibition of ERK1/2-phosphorylation (10 µmol/L U0126) prevented aldosterone-induced alkalinization. Furthermore, aldosterone induced proliferation of GMC and collagen secretion, both of which were prevented by U0126 and EIPA. Cytosolic calcium was not involved in this aldosterone action. In conclusion, our data show that aldosterone can induce GMC proliferation via a MR and ERK1/2-mediated activation of NHE with subsequent cytosolic alkalinization. GMC proliferation leads to glomerular hypercellularity and dysfunction. This effect presents a possible mechanism contributing to mineralocorticoid receptor-induced pathogenesis of glomerular mesangial injury during chronic kidney disease.

1. Introduction

Activation of the mineralocorticoid receptor promotes chronic inflammatory injury of non-epithelial tissue resulting in cardiovascular and renal damage [1,2,3,4,5,6,7]. Administration of the mineralocorticoid aldosterone to rats leads to glomerular injury with mesangial matrix expansion, cell overgrowth and proinflammatory signaling [8,9]. Furthermore, aldosterone stimulates glomerular mesangial cell (GMC) proliferation in culture [10]. Thus, GMC proliferation may contribute to aldosterone-induced renal injury [11].
The classical mechanism of aldosterone action involves binding to its intracellular receptor, transcription and protein synthesis. However, aldosterone can also induce rapid responses including intracellular pH and calcium, intracellular generation of inositol-1,4,5-trisphosphate (IP3) and protein kinase C activation [12,13,14,15,16,17,18,19,20,21,22]. A central common theme of rapid aldosterone action is furthermore activation of the Na+/H+-exchanger via extracellular signal-regulated kinases (ERK1/2) [23]. Several studies provide evidence that at least part of these rapid effects is mediated by the mineralocorticoid receptor (MR) [10,23,24,25,26,27,28,29,30,31]. Nishiyama et al. [10] showed rat glomerular mesangial cells (GMC) respond to aldosterone with a rapid activation of ERK1/2, which is required for aldosterone-induced proliferation of GMC. This study also provided evidence that the rapid effect is mediated by the MR.
Cell proliferation depends on a proper cytoplasmic pH homeostasis, maintained to a large extent by the Na+/H+-exchanger type 1 (NHE1) [32,33]. This is also true for GMC [34]. NHE1 is activated by growth factors, to a large extent via ERK1/2 [33,35], resulting in cytoplasmic alkalinization, which supports proliferation. Aldosterone can also stimulate NHE1 in an ERK1/2-dependent manner, leading to cytoplasmic alkalinization [36,37]. In the present study, we tested the hypothesis that aldosterone-induced proliferation of GMC depends on ERK1/2- and NHE1-mediated alkalinization.

2. Materials and Methods

2.1. Cell Culture

Rat glomerular mesangial cells (GMC) were prepared from male Sprague-Dawley rats by a sieving technique under sterile conditions. After collection of isolated glomeruli, “glomerular cores” were prepared by partial collagenase digestion and then plated in HEPES-buffered RPMI 1640 medium (Biochrom, Berlin, Germany) supplemented with 20% fetal calf serum (Merck KGaA, Darmstadt, Germany), 5 mg/L each of insulin (Sigma, St. Louis, MO, USA), transferrin (Sigma, St. Louis, MO, USA), as well as 5 µg/L sodium selenite (Sigma, St. Louis, MO, USA) at 37 °C in a humified 5% CO2-95% air mixture. After reaching confluence primary mesangial cells were subcultured every 7–10 days. GMC were identified by their typical morphology as well as by immunocytochemical and biochemical methods [38]. For the present study, GMC (passage 10–20) were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum, 5 mg/L each of insulin, transferrin, as well as 5 µg/L sodium selenite at 37 °C in a humified 5% CO2-95% air mixture. After growth to confluence, cells were washed once and made quiescent by 48 h incubation in supplement-free medium.

2.2. Determination of Cytosolic pH

Intracellular pH of single cells was determined using the pH-sensitive dye BCECF (Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA) as described elsewhere [39,40,41]. In brief, cells were incubated with 2 × 10−6 mol/L BCECF-AM for 5 min. Then, the coverslips were rinsed 4 times with superfusion solution, transferred to the stage of an inverted Axiovert 100 TV microscope (Zeiss, Oberkochen, Germany) and allowed to equilibrate for 15 min. Excitation light source was a 100 W mercury lamp. The excitation wavelengths were 490 nm/450 nm. The emitted light was filtered through a bandpass-filter (515–565 nm). The data acquisition rate was one fluorescence intensity ratio every 2 s. Images were digitized online using a video-imaging software (Hamamatsu, Herrsching, Germany). pH calibration was performed after each experiment by the nigericin (Sigma, St. Louis, MO, USA) technique [39,40], using at least three calibration solutions in the range from pH 6.8 to 7.8. The calibration solutions contained 115 mmol/L KCl and 30 mmol/L NaCl.

2.3. Determination of Cytosolic Free Calcium

Cytosolic free calcium was determined using the Ca2+ sensitive dye fura-2 (Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA) [42]. In brief, cells were incubated with fura-2 AM in a final concentration of 5 µmol/L for 15 min and mounted on the stage of an inverted Axiovert 100 TV microscope (400× magnification, oil immersion; Zeiss, Oberkochen, Germany). The fluorescence signal was monitored at 510 nm with excitation wavelength alternating between 334 and 380 nm using a 100 W xenon lamp. [Ca2+]i was calculated according to [42] using a Kd of 225 nmol/L. The maximum and minimum ratios (Rmax and Rmin) were measured after addition of calibration solutions, containing 1 µmol/L ionomycin (Sigma, St. Louis, MO, USA) and 1 mmol/L Ca2+ to determine Rmax or 1 mmol/L EGTA and no Ca2+ for Rmin, respectively. Possible artifacts were excluded by measurement of autofluorescence without fura-2.

2.4. Determination of Cell Number

Cell number was determined using a Coulter Counter Z2 series (Beckman, Indianapolis, IN, USA). Cells were seeded on plastic dishes and grown to subconfluence (ca. 40,000 cells/cm2). Cells were made quiescent by removal of additives and serum for 24 h. The experiments were carried out in medium without additives, in order to ensure that growth stimulation was solely dependent on addition of aldosterone.

2.5. Thymidine Incorporation

A 0.5 µL volume of the [3H]-thymidine stock solution (37 MBq/mL; Thermo Fisher Scientific, Waltham, MA, USA) was added to 1 mL of cell culture medium [43]. After 48 h the TCA-insoluble radioactivity was determined as follows: Cell were rinsed three times with phosphate-buffered saline at 4 °C, followed by one wash step with 10% TCA (15 min; Merck KGaA, Darmstadt, Germany) and two wash steps with 5% TCA (5 min) and a final wash step with ethanol. Subsequently, 0.5 mL NaOH (1 N) was added to each dish and incubated overnight. Thereafter, radioactivity was counted [43].

2.6. Determination of IP3 Formation

IP3 formation was determined by anion exchange columns [44]. In brief, Cells seeded in 6-well plates are preincubated during 24 h in media containing 0.5 µCi/mL [3H]-inositol (Thermo Fisher Scientific, Waltham, MA, USA). Prior to experimentation, radioactive medium was aspirated, the cells were washed with 3 × 2 mL HEPES-Ringer, and then incubated for 30 min in 2 mL HEPES-Ringer containing 15 mM LiCl (pH 7.4). This medium was replaced with 1 mL HEPES-Ringer + 15 mM LiCl and after 10 min of incubation at 37 °C 1 mL aliquots of control Ringer + 15 mM LiCl with desired agonists were added. After 15 min of incubation, cells were lysed with 1 mL of 4 mM EDTA/1% SDS (90 °C) and lysates were applied to ion exchange columns prepared as follows. An amount of 0.5 g of Dowex-AG 1X-8 (formate form; Bio-Rad, Munich, Germany) was laid into 5 mL pipette tips with cotton wool on the bottom. Applied samples were washed with 2 mL aliquots of H2O and 5 mM disodium tetraborate/60 mM sodium formate (Merck KGaA, Darmstadt, Germany) and then InsP1, InsP2 and InsP3 were eluted by subsequent addition of 2 mL of 0.1 M formic acid/0.2 M ammonium formate (InsP1), 0.1 M formic acid/0.4 M ammonium formate (InsP2) and 0.1 M formic acid/1.0 M ammonium formate (InsP3) (Merck KGaA, Darmstadt, Germany). Eluted InsP1-InsP3 were collected into scintillation vials, mixed with 10 mL of scintillation cocktail and counted.

2.7. Determination of Collagen Secretion by Collagenase-Sensitive Proline Incorporation

Total collagen secretion and total secreted protein were assessed by proline incorporation assay [45,46]. Cells were treated with aldosterone in the presence of 0.5 µCi/mL of [3H]proline (Thermo Fisher Scientific, Waltham, MA, USA), 50 mg/L ascorbic acid and 50 mg/L ß-aminoproprionitrile (Merck KGaA, Darmstadt, Germany). Determination of total secreted proteins or collagen was performed in the supernatants. Four hundred-microliter aliquots of supernatant from each well were incubated with 100 µL of collagenase assay buffer (50 mM Tris HCl, pH 7.5, 5 mM CaCl2, and 2.5 mM N-ethylmaleimide) containing 30 U/mL of collagenase (from Clostridium histolyticum, Sigma, St. Louis, MO, USA) for 4 h at 37 °C. In parallel, a second 400-µL aliquot was incubated in assay buffer without collagenase. Then, 50 µL of FBS and 100 µL of TCA (Merck KGaA, Darmstadt, Germany) were added to the samples and incubated on ice for 30 min to precipitate protein fractions. Precipitates were washed three times with 2 mL of TCA and two times with 2 mL of 80% ethanol. Finally, precipitates were dissolved in 1 M NaOH and radioactivity determined by liquid scintillation counting. Amounts of total secreted proteins were calculated as disintegrations per minute (dpm) in supernatants without collagenase. Secreted collagen was calculated as dpm in supernatants without collagenase minus dpm in supernatants with collagenase. The percentage of total protein secreted as collagen (%collagen) was calculated as the ratio of collagenase-releasable dpm divided by total dpm as follows: %collagen = (C/P)/[[5.4 × (1-C/P)] + (C/P)] × 100, where C is collagenase-releasable dpm in supernatants and P is collagenase-insensitive dpm in pellets. A correction factor of 5.4 for noncollagen protein was used to adjust for the relative abundance of proline and hydroxyproline in proteins containing collagen.

2.8. Western Blot

Western blotting was performed according to standard protocols. Cells were lysed (0.5 M Tris-HCl pH 6.8; 10% SDS; 10% 2-Mercaptoethanol; 20% Glycerol; 0.01% Bromphenolblue; Sigma, St. Louis, MO, USA), separated by SDS-PAGE and transferred to a nitrocellulose membrane. Subsequently, membranes were incubated with antibodies specific for phospho-ERK1/2 or total ERK1/2 (Cell Signaling, Frankfurt, Germany). The bound primary antibody was visualized using horseradish peroxidase (HRP)-conjugated secondary antibodies and Serva chemoluminescence reagent for HRP (Serva, Heidelberg, Germany) with the Molecular Imager ChemiDoc XRS System (Bio-Rad, Munich, Germany). Quantitative analysis was performed with Quantity One software, version 4.6.9 (Bio-Rad, Munich, Germany).

2.9. Materials

Aldosterone, 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) and ethyl-isopropanol-amiloride (EIPA) were obtained from Sigma (St. Louis, MO, USA), U0126 is from Tocris Cookson (Bristol, UK). The inhibitors were used at appropriate published concentrations EIPA [47,48], U0126 [49], DIDS [50] and BIM [51,52]. All other applied chemicals were of analytical grade and obtained from Merck, Darmstadt, Germany. HCO3− Ringer solution was composed of (mmol/L): NaCl 108, KCl 5.4, CaCl2 1.2, MgCl2 0.8, NaH2PO4 1.0, NaHCO3 24, glucose 5.5, 5% CO2. HEPES-Ringer solution was composed of (mmol/L): NaCl 124.5, KCl 5.4, CaCl2 1.2, MgCl2 0.8, NaH2PO4 1.0, HEPES 10, glucose 5.5, pH 7.4. Control solutions always contained the appropriate amount of vehicle (DMSO or ethanol, <1‰).

2.10. Statistics

The data are presented as mean values ± SEM. Significance of difference was tested by paired or unpaired Student’s t-test or ANOVA, as applicable. Differences were considered significant if p < 0.05. Cells from at least three different passages were used for each experimental series. N represents the number of cells or tissue culture dish investigated. For pH and calcium determinations at least five cover slips from at least three different passages were investigated for each experimental condition.

3. Results

3.1. Aldosterone-Induced Changes in Cytosolic pH

As shown in Figure 1A, aldosterone exerts a rapid biphasic effect on cytosolic pH, similar to the one described in vascular smooth muscle cells [21]. In HEPES-buffered saline, addition of 10 nmol/L aldosterone induced an initial transient acidification followed by a sustained alkalinization (Figure 1A). A similar effect was observed in HCO3−/CO2-buffered saline (Figure 1B). In the presence of 1 nmol/L aldosterone, we observed a similar biphasic response (Figure 1C).
To exclude that the observed effects represent spontaneous pH changes, we performed time controls. As shown in Figure 1D, the aldosterone-induced effects were not the result of spontaneous pH changes. We observed a slight decline in cytosolic pH over time, indicating that aldosterone-induced acidification might be slightly overestimated. Figure 1E summarizes the pH values under control conditions, during the acidification phase and during sustained alkalinization. Because cytosolic pH reaches a new steady state at more alkaline values, we hypothesized that H+-transport systems responsible for the control of cellular pH homeostasis are affected. The most likely candidate is the Na+/H+-exchanger, shown to be stimulated by aldosterone in other cell types [23].

3.2. Pharmacology of Aldosterone-Induced Changes in Cytosolic pH

To characterize the aldosterone-induced pH changes in more detail, we used a pharmacological approach. We tested the effect of EIPA (a well-established Na+/H+-exchange inhibitor [47]) and DIDS (an inhibitor of Cl− and HCO3− transport [53]). As shown in Figure 2A, EIPA (10 µmol/L) completely prevented aldosterone-induced alkalinization.
In contrast, DIDS (200 µmol/L, Figure 2B) was without effect. The results are summarized in Figure 2E. Aldosterone-induced acidification could not be prevented by either EIPA or DIDS. At present, the underlying mechanism for GMC acidification is not known.
Rapid activation of NHE1 can be mediated through ERK1/2 [33,47]. Because it had been shown that aldosterone activated ERK1/2 in GMC with a similar time course to that in which alkalinization occurs [10], which we could confirm as shown in Figure 3E, we tested whether inhibition of ERK1/2 activation interfered with the alkalinizing effect of aldosterone. Blockade of ERK1/2 activation with 1 µmol/L U0126 [54] prevented aldosterone-induced alkalinization (Figure 2C). Furthermore, alkalinization could be prevented by inhibition of protein kinase C with 200 nmol/L bisindolylmaleimide (BIM; Figure 2D). The results are summarized in Figure 2E. Aldosterone-induced acidification was not prevented by either U0126 or BIM. Previously, it has been reported that BIM exerts no effect on MR transcriptional activity [55]. By contrast, ERK1/2 is required for regular nuclear translocation [31], which leads to the modulation of transcriptional activity. By contrast, DIDS has been shown not to prevent transcriptional effects of aldosterone [56]. Similarly, EIPA did not prevent MR-induced upregulation of sodium channel expression [57].

3.3. Aldosterone-Induced Cell Proliferation and Collagen Secretion

Because ERK1/2 and alkalinization play a role in the regulation of cell proliferation, we investigated whether aldosterone affects proliferation of rat mesangial cells, and if so, whether this effect can be prevented by U0126 and EIPA. Figure 3 shows that 48 h incubation with aldosterone led to a significant increase in cell number and thymidine incorporation compared to control conditions.
Because cell number was constant under control conditions (Figure 3A), these data show that aldosterone indeed induced proliferation and did not just prevent a reduction in cell number. Furthermore, the aldosterone-induced increase in cell number was prevented by U0126 (Figure 3B,C), indicating that ERK1/2 activation was necessary for proliferation, as already suggested before [10]. Proliferation was also inhibited by 10 µmol/L EIPA (Figure 3B,C). Thus, aldosterone-induced stimulation of NHE1 supports the proliferative action the hormone.
Aldosterone enhanced the amount of secreted collagen significantly (Figure 3D). If this effect were to occur in the intact glomerulum, it would promote glomerulosclerosis. In the presence of spironolactone, U0126 or EIPA, aldosterone did not enhance collagen secretion (Figure 3D). To determine whether enhanced extracellular collagen resulted from a specific stimulation of collagen secretion or was the result of a more general enhancement of protein secretion (due to the increased cell number), we determined the percentage of total protein secreted as collagen. Aldosterone did not affect this parameter significantly (21.02 ± 2.68% under control conditions versus 24.49 ± 2.64% in the presence of aldosterone; n = 8). These data imply that enhanced extracellular collagen was a result of the increase in cell number. Of course, these data do not rule out that less abundant types of collagen were induced specifically by aldosterone.

3.4. No Contribution of Cytosolic Ca2+ to Aldosterone-Induced Alkalinisation or Cell Proliferation

Aldosterone exerted a minor effect on cytosolic Ca2+ concentration (Figure 4A) that resulted from Ca2+ influx and was not accompanied by IP3 formation, in contrast to the positive control ADH (Figure 4B–D). Preventing Ca2+ influx by lowering extracellular Ca2+ did not prevent aldosterone-induced cytosolic alkalinization (Figure 4E). Furthermore, buffering of intracellular Ca2+ did not prevent the aldosterone-induced increase in cell number (Figure 4F).

4. Discussion

Our data show that aldosterone induces rapid cytosolic alkalinization in glomerular mesangial cells (Figure 5). This effect is independent of HCO3−, indicating that HCO3− transports are not involved. The lack of effect of DIDS supports this conclusion. By contrast, the pharmacological data indicate that aldosterone stimulates Na+/H+ exchange in glomerular mesangial cells, similar to its effect in other cell systems [58]. Because (i) only isoform 1 of Na+/H+ exchange has been detected in rat glomerular mesangial cells [59] and (ii) EIPA at 10 µmol/L prevented alkalinization completely, we conclude that aldosterone stimulates Na+/H+-exchange type 1 (NHE1). Aldosterone-induced acidification could not be prevented by either EIPA or DIDS. At present, the mechanisms underlying acidification in GMC are not known, as is the case for other cell types, like vascular smooth muscle cells [21].
The inhibitory effect of U0126 on aldosterone-induced alkalinization, taken together with known aldosterone-induced ERK1/2 activation in GMC [10], indicates that the activation of NHE1 in rat mesangial cells by aldosterone is mediated by ERK1/2. Aldosterone-induced stimulation of NHE1 via ERK1/2 has also been reported for MDCK and M-1 cells [37,60]. Therefore, the effects observed in GMC and other cells seem to describe a mechanism of action of aldosterone with broader significance. Furthermore, we provide evidence for an involvement of protein kinase C (inhibitory effect of BIM) but not of IP3, indicating that the classical phospholipase Cβ is most probably not involved. Our data do make it possible to define the relevant PKC isoform nor to conclude whether PKC activity has to be increased or just exerts a permissive role. Although the effect of aldosterone is rapid, it seems to be mediated by the mineralocorticoid receptor, indicated by the inhibitory action of spironolactone, which is also responsible for a variety of non-genotropic aldosterone effects [31].
Because cell proliferation depends on a proper cytoplasmic pH homeostasis [32,33], the importance of aldosterone-induced alkalinization may arise from its contribution to cell growth. Our data on cell proliferation confirm the study by Nishiyama et al. [10], showing that aldosterone stimulates GMC proliferation via ERK1/2. Furthermore, our data show that this proliferation requires cytoplasmic alkalinization via NHE1 activation, because inhibition of NHE1 abrogates proliferation. Thus, our data add one additional piece to the puzzle of aldosterone-induced proliferation of GMC, which depends on ERK1/2 and NHE1. Finally, aldosterone-induced proliferation leads to enhanced collagen secretion. At present, we do not know whether a specific type of collagen is affected or whether it is an overall increase of collagen secretion, but we will address this issue in future studies. If the proliferation and collagen data also hold true for the in vivo situation, they would nicely help to explain sclerosis of glomeruli.

5. Conclusions

MR activation, e.g., by aldosterone, is part of progressive inflammatory renal damage independently of blood pressure [61], and the glomerular mesangium seems to be a major target. Our data suggest that the underlying pathomechanisms leading to glomerular mesangial injury include ERK1/2- and NHE1-induced proliferation of GMC and thereby to glomerular hypercellularity and dysfunction. Knowledge of the cellular mechanisms leads to a better understanding of the pathophysiology of renal injury and may help to develop therapeutic strategies.

Author Contributions

Conceptualization, M.G.; pH and calcium measurements, M.G.; measurement of cell number, thymidine incorporation, collagen synthesis, IP3 formation and cell culture, S.M.; formal data analysis, M.G., S.M.; data curation, M.G.; writing—original draft preparation, M.G.; writing—review and editing, M.G., S.M.; visualization, M.G.; project administration, M.G.; funding acquisition, M.G. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Deutsche Forschungsgemeinschaft (Grants Ge 905/4-4 and 8-1).

Institutional Review Board Statement

Experiments were performed according to the legal rules of the Federal Republic of Germany. They were approved by the Regierung von Unterfranken, Wuerzburg, Germany.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hollenberg, N.K. Aldosterone in the development and progression of renal injury. Kidney Int. 2004, 66, 1–9. [Google Scholar] [CrossRef] [Green Version]
  2. Sato, A.; Hayashi, K.; Naruse, M.; Saruta, T. Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy. Hypertension 2003, 41, 64–68. [Google Scholar] [CrossRef] [Green Version]
  3. Rachmani, R.; Slavachevsky, I.; Amit, M.; Levi, Z.; Kedar, Y.; Berla, M.; Ravid, M. The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: A randomized controlled study. Diabet. Med. 2004, 21, 471–475. [Google Scholar] [CrossRef]
  4. Williams, G.H.; Burgess, E.; Kolloch, R.E.; Ruilope, L.M.; Niegowska, J.; Kipnes, M.S.; Roniker, B.; Patrick, J.L.; Krause, S.L. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am. J. Cardiol. 2004, 93, 990–996. [Google Scholar] [CrossRef]
  5. White, W.B.; Duprez, D.; St Hillaire, R.; Krause, S.; Roniker, B.; Kuse-Hamilton, J.; Weber, M.A. Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension. Hypertension 2003, 41, 1021–1026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Briet, M.; Schiffrin, E.L. Aldosterone: Effects on the kidney and cardiovascular system. Nat. Rev. Nephrol. 2010, 6, 261–273. [Google Scholar] [CrossRef] [PubMed]
  7. Kiyomoto, H.; Rafiq, K.; Mostofa, M.; Nishiyama, A. Possible Underlying Mechanisms Responsible for Aldosterone and Mineralocorticoid Receptor-Dependent Renal Injury. J. Pharmacol. Sci. 2008, 108, 399–405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Nishiyama, A.; Yao, L.; Nagai, Y.; Miyata, K.; Yoshizumi, M.; Kagami, S.; Kondo, S.; Kiyomoto, H.; Shokoji, T.; Kimura, S.; et al. Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats. Hypertension 2004, 43, 841–848. [Google Scholar] [CrossRef] [Green Version]
  9. Terada, Y.; Ueda, S.; Hamada, K.; Shimamura, Y.; Ogata, K.; Inoue, K.; Taniguchi, Y.; Kagawa, T.; Horino, T.; Takao, T. Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin. Exp. Nephrol. 2012, 16, 81–88. [Google Scholar] [CrossRef]
  10. Nishiyama, A.; Yao, L.; Fan, Y.; Kyaw, M.; Kataoka, N.; Hashimoto, K.; Nagai, Y.; Nakamura, E.; Yoshizumi, M.; Shokoji, T.; et al. Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability. Hypertension 2005, 45, 710–716. [Google Scholar] [CrossRef] [PubMed]
  11. Shrestha, A.; Che, R.C.; Zhang, A.H. Role of Aldosterone in Renal Fibrosis; Springer: Singapore, 2019; pp. 325–346. [Google Scholar]
  12. Oberleithner, H.; Weigt, M.; Westphale, H.-J.; Wang, W. Aldosterone activates Na+/H+ exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc. Natl. Acad. Sci. USA 1987, 84, 1464–1468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Christ, M.; Eisen, C.; Aktas, J.; Theisen, K.; Wehling, M. The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes. J. Clin. Endocr. Metab. 1993, 77, 1452–1457. [Google Scholar]
  14. Vilella, S.; Guerra, L.; Helmle-Kolb, C.; Murer, H. Aldosterone actions on basolateral Na+/H+ exchange in Madin-Darby canine kidney cells. Pflügers Arch. 1992, 422, 9–15. [Google Scholar] [CrossRef] [PubMed]
  15. Cooper, G.J.; Hunter, M. Na+-H+ exchange in frog early distal tubule: Effect of aldosterone on the set-point. J. Physiol. 1994, 479, 423–432. [Google Scholar] [CrossRef] [Green Version]
  16. Doolan, C.M.; Harvey, B.J. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J. Biol. Chem. 1996, 271, 8763–8767. [Google Scholar] [CrossRef] [Green Version]
  17. Gekle, M.; Golenhofen, N.; Oberleithner, H.; Silbernagl, S. Rapid activation of Na+/H+-exchange by aldosterone in renal epithelial cells requires Ca2+ and stimulation of a plasma membrane proton conductance. Proc. Natl. Acad. Sci. USA 1996, 93, 10500–10504. [Google Scholar] [CrossRef] [Green Version]
  18. Christ, M.; Douwes, K.; Eisen, C.; Bechtner, G.; Theisen, K.; Wehling, M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 1995, 25, 117–123. [Google Scholar] [CrossRef]
  19. Wehling, M.; Neylon, C.B.; Fullerton, M.; Bobik, A.; Funder, J.W. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ. Res. 1995, 76, 973–979. [Google Scholar] [CrossRef]
  20. Wehling, M.; Ulsenheimer, A.; Schneider, M.; Neylon, C.; Christ, M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: Subcellular localization of calcium elevations by single cell imaging. Biochem. Biophys. Res. Commun. 1994, 204, 475–481. [Google Scholar] [CrossRef] [PubMed]
  21. Wehling, M.; Bauer, M.M.; Ulsenheimer, A.; Schneider, M.; Neylon, C.B.; Christ, M. Nongenomic effects of aldosterone on intracellular pH in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1996, 223, 181–186. [Google Scholar] [CrossRef] [PubMed]
  22. Fiebeler, A.; Haller, H. Participation of the mineralocorticoid receptor in cardiac and vascular remodeling. Nephron Physiol. 2003, 94, 47–50. [Google Scholar] [CrossRef] [PubMed]
  23. Losel, R.; Wehling, M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 2003, 4, 46–56. [Google Scholar] [CrossRef]
  24. Callera, G.E.; Touyz, R.M.; Tostes, R.C.; Yogi, A.; He, Y.; Malkinson, S.; Schiffrin, E.L. Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src. Hypertension 2005, 45, 773–779. [Google Scholar] [CrossRef] [Green Version]
  25. Cato, A.C.B.; Nestl, A.; Mink, S. Rapid actions of steroid receptors in cellular signaling pathways. Sci. STKE 2002, 138, re9. [Google Scholar] [CrossRef] [PubMed]
  26. Alzamora, R.; Michea, L.; Marusic, E.T. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 2000, 35, 1099–1104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Uhrenholt, T.R.; Schjerning, J.; Hansen, P.B.; Norregaard, R.; Jensen, B.L.; Sorensen, G.L.; Skott, O. Rapid Inhibition of Vasoconstriction in Renal Afferent Arterioles by Aldosterone. Circ. Res. 2003, 93, 1258–1266. [Google Scholar] [CrossRef] [Green Version]
  28. Liu, S.L.; Schmuck, S.; Chorazcyzewski, J.Z.; Gros, R.; Feldman, R.D. Aldosterone Regulates Vascular Reactivity: Short-Term Effects Mediated by Phosphatidylinositol 3-Kinase-Dependent Nitric Oxide Synthase Activation. Circulation 2003, 108, 2400–2406. [Google Scholar] [CrossRef] [Green Version]
  29. Mazak, I.; Fiebeler, A.; Muller, D.N.; Park, J.K.; Shagdarsuren, E.; Lindschau, C.; Dechend, R.; Viedt, C.; Pilz, B.; Haller, H.; et al. Aldosterone Potentiates Angiotensin II-Induced Signaling in Vascular Smooth Muscle Cells. Circulation 2004, 109, 2792–2800. [Google Scholar] [CrossRef] [Green Version]
  30. Braun, S.; Lösel, R.M.; Wehling, M.; Boldyreff, B. Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84. FEBS Lett. 2004, 570, 69–72. [Google Scholar] [CrossRef] [Green Version]
  31. Grossmann, C.; Benesic, A.; Krug, A.W.; Freudinger, R.; Mildenberger, S.; Gassner, B.; Gekle, M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 2005, 19, 1697–1710. [Google Scholar] [CrossRef] [Green Version]
  32. Pouysségur, J.; Sardet, C.; Franchi, A.; L’Allemain, G.; Paris, S. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc. Natl. Acad. Sci. USA 1984, 81, 4833–4837. [Google Scholar] [CrossRef] [Green Version]
  33. Wakabayashi, S.; Shigekawa, M.; Pouysségur, J. Molecular physiology of vertebrate Na+/H+ exchangers. Physiol. Rev. 1997, 77, 51–67. [Google Scholar] [CrossRef] [PubMed]
  34. Ganz, M.B.; Perfetto, M.C.; Boron, W.F. Effects of mitogens and other agents on rat mesangial cell proliferation, pH, and Ca2+. Am. J. Physiol. 1990, 259, F269–F278. [Google Scholar] [CrossRef] [PubMed]
  35. Bianchini, L.; L’Allemain, G.; Pouysségur, J. The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of Na+/H+ exchanger (NHE1 isoform) in response to growth factors. J. Biol. Chem. 1997, 272, 271–279. [Google Scholar] [CrossRef] [Green Version]
  36. Gekle, M.; Freudinger, R.; Mildenberger, S.; Silbernagl, S. Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. Am. J. Physiol. Ren. Physiol. 2002, 282, F669–F679. [Google Scholar] [CrossRef] [Green Version]
  37. Gekle, M.; Freudinger, R.; Mildenberger, S.; Schenk, K.; Marschitz, I.; Schramek, H. Rapid activation of Na+/H+-exchange in MDCK-cells by aldosterone involves MAP-kinases ERK1/2. Pflügers Arch. 2001, 441, 781–786. [Google Scholar] [CrossRef]
  38. Schramek, H.; Schumacher, M.; Pfaller, W. Sustained ERK-2 activation in rat glomerular mesangial cells: Differential regulation by protein phosphatases. Am. J. Physiol. 1996, 271, F423–F432. [Google Scholar] [CrossRef]
  39. Weiner, I.D.; Hamm, L.L. Use of fluorescent dye BCECF to measure intracellular pH in cortical collecting tubule. Am. J. Physiol. 1989, 256, F957–F964. [Google Scholar] [CrossRef]
  40. Thomas, J.A.; Buchsbaum, R.N.; Zimniak, A.; Racker, E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979, 18, 2210–2218. [Google Scholar] [CrossRef] [PubMed]
  41. Dreher, D.; Rochat, T. Hyperoxia induces alkalinization and dome formation in MDCK epithelial cells. Am. J. Physiol. 1992, 262, C358–C364. [Google Scholar] [CrossRef]
  42. Grynkiewicz, G.; Poenie, M.; Tsien, R.Y. A new generation of Ca2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 1985, 260, 3440–3450. [Google Scholar] [CrossRef]
  43. Whiteside, C.; Munk, S.; Zhou, X.; Miralem, T.; Templeton, D.M. Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness. J. Am. Soc. Nephrol. 1998, 9, 14–25. [Google Scholar] [CrossRef]
  44. Orlov, S.N.; Resink, T.J.; Bernhardt, J.; Buhler, F.R. Volume-dependent regulation of sodium and potassium fluxes in cultured vascular smooth muscle cells: Dependence on medium osmolality and regulation. J. Membr. Biol. 1992, 129, 199–210. [Google Scholar] [CrossRef]
  45. Gekle, M.; Knaus, P.; Nielsen, R.; Mildenberger, S.; Freudinger, R.; Wohlfarth, V.; Sauvant, C.; Christensen, E.I. TGF- 1 reduces megalin/cubilin-mediated endocytosis of albumin in proximal tubule derived OK-cells. J. Physiol. 2003, 552, 471–481. [Google Scholar] [CrossRef]
  46. Wohlfarth, V.; Drumm, K.; Mildenberger, S.; Freudinger, R.; Gekle, M. Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells. Kidney Int. 2003, 63 (Suppl. 84), 103–109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Noel, J.; Pouysségur, J. Hormonal regulation, pharmacology, and membrane sorting of vertebrate Na+/H+ exchanger isoforms. Am. J. Physiol. 1995, 268, C283–C296. [Google Scholar] [CrossRef] [PubMed]
  48. Masereel, B.; Pochet, L.; Laeckmann, D. An overview of inhibitors of Na+/H+ exchanger. Eur. J. Med. Chem. 2003, 38, 547–554. [Google Scholar] [CrossRef]
  49. Favata, M.F.; Horiuchi, K.Y.; Manos, E.J.; Daulerio, A.J.; Stradley, D.A.; Feeser, W.S.; Van Dyk, D.E.; Pitts, W.J.; Earl, R.A.; Hobbs, F.; et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase. J. Biol. Chem. 1998, 273, 18623–18632. [Google Scholar] [CrossRef] [Green Version]
  50. Emmons, C. Transport characteristics of the apical anion exchanger of rabbit cortical collecting duct ß-cells. Am. J. Physiol.-Ren. Physiol. 1999, 276, F635–F643. [Google Scholar] [CrossRef] [PubMed]
  51. Martiny-Baron, G.; Kazanietz, M.G.; Mischak, H.; Blumberg, P.M.; Kochs, G.; Hug, H.; Marmé, D.; Schächtele, C. Selective inhibition of protein kinase C isozymes by the indolocarbazole GÃ 6976. J. Biol. Chem. 1993, 268, 9194–9197. [Google Scholar] [CrossRef]
  52. Gschwendt, M.; Dieterich, S.; Rennecke, J.; Kittstein, W.; Mueller, H.J.; Johannes, F.J. Inhibition of protein kinase C by various inhibitors. Inhibition from protein kinase c isoenzymes. FEBS Lett. 1996, 392, 77–80. [Google Scholar] [CrossRef] [Green Version]
  53. Weiner, I.D.; Weill, A.E.; New, A.R. Distribution of Cl−/HCO3− exchange and intercalated cells in rabbit cortical collecting duct. Am. J. Physiol. 1994, 267, F952–F964. [Google Scholar] [CrossRef] [PubMed]
  54. Krug, A.W.; Schuster, C.; Gassner, B.; Freudinger, R.; Mildenberger, S.; Troppmair, J.; Gekle, M. Human EGF receptor 1 (HER1) expression renders CHO cells sensitive to alternative aldosterone signaling. J. Biol. Chem. 2002, 277, 45892–45897. [Google Scholar] [CrossRef] [Green Version]
  55. Pfau, A.; Grossmann, C.; Freudinger, R.; Mildenberger, S.; Benesic, A.; Gekle, M. Ca2+ but not H2O2 modulates GRE-element activation by the human mineralocorticoid receptor in HEK cells. Mol. Cell. Endocrinol. 2007, 264, 35–43. [Google Scholar] [CrossRef] [PubMed]
  56. Good, D.W.; George, T.; Watts, B.A. Nongenomic regulation by aldosterone of the epithelial NHE3 Na+/H+ exchanger. Am. J. Physiol.-Cell Physiol. 2006, 290, C757–C763. [Google Scholar] [CrossRef] [Green Version]
  57. Kornel, L.; Smoszna-Konaszewska, B. Aldosterone (ALDO) increases transmembrane influx of Na+ in vascular smooth muscle (VSM) cells through increased synthesis of Na+ channels. Steroids 1995, 60, 114–119. [Google Scholar] [CrossRef]
  58. Wehling, M. Specific, nongenomic actions of steroid homones. Annu. Rev. Physiol. 1997, 59, 365–393. [Google Scholar] [CrossRef]
  59. Schulte, E.A.; Hohendahl, A.; Stegemann, H.; Hirsch, J.R.; Schlatter, E. Natriuretic peptides and diadenosine polyphosphates modulate pH regulation of rat mesangial cells. Cell. Physiol. Biochem. 2000, 9, 310–322. [Google Scholar] [CrossRef]
  60. Markos, F.; Healy, V.; Harvey, B.J. Aldosterone rapidly activates Na+/H+ exchange in M-1 cortical collecting duct cells via a PKC-MAPK pathway. Nephron Physiol. 2005, 99, 1–9. [Google Scholar] [CrossRef] [PubMed]
  61. Epstein, M. Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications. Am. J. Kidney Dis. 2001, 37, 677–688. [Google Scholar]
Biomedicines 09 01117 g001 550
Figure 1. (A) Aldosterone induces a rapid and biphasic change in cytosolic pH. Transient acidification is followed by sustained alkalinization. (B) Aldosterone-induced pH-changes are also observed in HCO3−/CO2-buffered Ringer-solution. (C) pH-changes are also observed with 1 nmol/L aldosterone. (D) Time control experiments in HCO3−/CO2-buffered Ringer-solution show that cytosolic pH does not increase under control conditions. (E) Summary of the pH-values before addition of aldosterone (control), during maximum acidification (4 min) and when the plateau of alkalinization was reached (12 min). N = 70–120 for each condition. * = p < 0.05 versus control.
Figure 1. (A) Aldosterone induces a rapid and biphasic change in cytosolic pH. Transient acidification is followed by sustained alkalinization. (B) Aldosterone-induced pH-changes are also observed in HCO3−/CO2-buffered Ringer-solution. (C) pH-changes are also observed with 1 nmol/L aldosterone. (D) Time control experiments in HCO3−/CO2-buffered Ringer-solution show that cytosolic pH does not increase under control conditions. (E) Summary of the pH-values before addition of aldosterone (control), during maximum acidification (4 min) and when the plateau of alkalinization was reached (12 min). N = 70–120 for each condition. * = p < 0.05 versus control.
Biomedicines 09 01117 g001
Biomedicines 09 01117 g002 550
Figure 2. (A) The Na+/H+-exchange inhibitor EIPA prevents aldosterone-induced alkalinization. (B) Inhibition of HCO3−-transporters with DIDS does not prevent aldosterone-induced alkalinization. (C) Aldosterone-induced alkalinization is abolished when ERK1/2-activation is prevented by U0126. (D) Aldosterone-induced alkalinization is abolished by PKC inhibition with BIM. (E) Summary of the pH-changes under the different conditions. N = 60–100 for each condition. * = p < 0.05 versus control.
Figure 2. (A) The Na+/H+-exchange inhibitor EIPA prevents aldosterone-induced alkalinization. (B) Inhibition of HCO3−-transporters with DIDS does not prevent aldosterone-induced alkalinization. (C) Aldosterone-induced alkalinization is abolished when ERK1/2-activation is prevented by U0126. (D) Aldosterone-induced alkalinization is abolished by PKC inhibition with BIM. (E) Summary of the pH-changes under the different conditions. N = 60–100 for each condition. * = p < 0.05 versus control.
Biomedicines 09 01117 g002
Biomedicines 09 01117 g003 550
Figure 3. (A) Cell number is stable over a 48 h period in minus media. (B,C) Aldosterone (aldo, 10 nmol/L) induced proliferation of GMC proliferation is prevented by inhibition of Na+/H+-exchange (EIPA), by inhibition of ERK1/2-phosphorylation (U0126) and by blockade of the mineralocorticoid receptor (spiro). N = 10. * = p < 0.05 versus respective control. (D) Aldosterone (aldo, 10 nmol/L) induced proliferation collagen secretion is prevented by inhibition of Na+/H+-exchange (EIPA), by inhibition of ERK1/2-phosphorylation (U0126) and by blockade of the mineralocorticoid receptor (spiro). N = 8. * = p < 0.05 versus respective control. (E) Aldosterone (10 nmol/L, 15 min) enhances ERK1/2 phosphorylation (ppERK1/2).
Figure 3. (A) Cell number is stable over a 48 h period in minus media. (B,C) Aldosterone (aldo, 10 nmol/L) induced proliferation of GMC proliferation is prevented by inhibition of Na+/H+-exchange (EIPA), by inhibition of ERK1/2-phosphorylation (U0126) and by blockade of the mineralocorticoid receptor (spiro). N = 10. * = p < 0.05 versus respective control. (D) Aldosterone (aldo, 10 nmol/L) induced proliferation collagen secretion is prevented by inhibition of Na+/H+-exchange (EIPA), by inhibition of ERK1/2-phosphorylation (U0126) and by blockade of the mineralocorticoid receptor (spiro). N = 8. * = p < 0.05 versus respective control. (E) Aldosterone (10 nmol/L, 15 min) enhances ERK1/2 phosphorylation (ppERK1/2).
Biomedicines 09 01117 g003
Biomedicines 09 01117 g004 550
Figure 4. (A) Aldosterone (10 nmol/L) induces only a minor increase in cytosolic Ca2+, in contrast to (B) 100 nmol/L ADH. (C) ADH but not aldosterone induces the formation of IP3 (N = 5). (D) At low extracellular Ca2+, to prevent relevant Ca2+ influx, aldosterone induces no increase of cytosolic Ca2+. (E) Aldosterone-induced alkalinisation and (F) aldosterone-induced increase in cell number are independent of extracellular Ca2+ (N = 10). * = p < 0.05 versus respective control.
Figure 4. (A) Aldosterone (10 nmol/L) induces only a minor increase in cytosolic Ca2+, in contrast to (B) 100 nmol/L ADH. (C) ADH but not aldosterone induces the formation of IP3 (N = 5). (D) At low extracellular Ca2+, to prevent relevant Ca2+ influx, aldosterone induces no increase of cytosolic Ca2+. (E) Aldosterone-induced alkalinisation and (F) aldosterone-induced increase in cell number are independent of extracellular Ca2+ (N = 10). * = p < 0.05 versus respective control.
Biomedicines 09 01117 g004
Biomedicines 09 01117 g005 550
Figure 5. Graphical summary of the described effects of aldosterone. MR = mineralocorticoid receptor. PKC = protein kinase C. ERK1/2 = extracellular signal regulated kinase 1/2.
Figure 5. Graphical summary of the described effects of aldosterone. MR = mineralocorticoid receptor. PKC = protein kinase C. ERK1/2 = extracellular signal regulated kinase 1/2.
Biomedicines 09 01117 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gekle, M.; Mildenberger, S. Glomerular Mesangial Cell pH Homeostasis Mediates Mineralocorticoid Receptor-Induced Cell Proliferation. Biomedicines 2021, 9, 1117. https://doi.org/10.3390/biomedicines9091117

AMA Style

Gekle M, Mildenberger S. Glomerular Mesangial Cell pH Homeostasis Mediates Mineralocorticoid Receptor-Induced Cell Proliferation. Biomedicines. 2021; 9(9):1117. https://doi.org/10.3390/biomedicines9091117

Chicago/Turabian Style

Gekle, Michael, and Sigrid Mildenberger. 2021. "Glomerular Mesangial Cell pH Homeostasis Mediates Mineralocorticoid Receptor-Induced Cell Proliferation" Biomedicines 9, no. 9: 1117. https://doi.org/10.3390/biomedicines9091117

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop